Drug Industry Embraces New Business Strategies After Tough Year

As they pop the champagne corks to celebrate New Year’s Eve, drug industry executives will likely be glad to put 2009 behind them. That’s because pharmaceutical companies who make top-selling drugs for heart disease, asthma, and many other conditions had a tough year in the midst of mounting market pressures and a global recession. A timely year-end analysis of the state of the pharmaceutical industry is scheduled for the current issue of Chemical & Engineering News, ACS’ weekly newsmagazine…

Read the rest here:
Drug Industry Embraces New Business Strategies After Tough Year

Related posts:

1. European Commission And Biopharmaceutical Industry Lay Out Steps To Improve Business Environment For Sector SMEs EBE, the European Biopharmaceutical Enterprises and the European Commission's Enterprise and Industry Directorate General today jointly presented a workshop on access to finance for small and medium-sized biopharmaceutical companies in...
2. Booming Business In Food Safety Fueled By Recalls, Food Worries Recalls of ground beef, peanut butter, and other foods have done more than raise public awareness and concern about food safety. They also are quietly fueling a boom in the...
3. Association Of The British Pharmaceutical Industry Welcomes Patent Box The Association of the British Pharmaceutical Industry (ABPI) has welcomed the proposal for a 'patent box' outlined by Chancellor Alastair Darling in his Pre-Budget Report. The patent box is being...
4. Climate Debate: What’s Warming Us Up? Human Activity Or Mother Nature? A major analysis of the climate debate concludes that the majority of scientists agree that global warming is primarily man-made, although a vocal minority of skeptics is holding onto the...
5. Aptuit Publishes Study Which Demonstrates The Value Of Early Insights Into The Characterization Of Drug Compounds Aptuit, Inc. announced the publication of new research in the December issue of the European Journal of Pharmaceutical Sciences, the official journal of the European Federation for Pharmaceutical Sciences (EUFEPS),...
6. PlusNews Examines Push To Evaluate HIV Prevention Strategies PlusNews examines the growing need to test how well HIV prevention strategies work - a topic addressed Monday at a Social Aspects of HIV/AIDS Research Alliance (SAHARA) conference in Johannesburg,...
7. Student’s Award For Study Into Cancer Drug Target A PhD student at The Institute of Cancer Research (ICR) has won an Europe-wide competition for her investigation into a promising anti-cancer drug target. Nicole Simonavicius was awarded first prize...
8. Alcohol Industry Should Prove No Harm In Funding Of Sports Researchers from Australia and the UK are calling for a new approach to the debate over whether alcohol industry sponsorship of sports increases drinking among sports participants. They want to...
9. Ohr Pharmaceutical Data Review Supports The Strong Potential Of Its Lead Drug OHR/AVR118 For Cachexia Ohr Pharmaceutical Inc. (OTCBB: OHRP) is developing OHR/AVR118 for treatment of cachexia based on technology acquired earlier this year from Advanced Viral Research Corp. OHR/AVR118 has shown excellent therapeutic efficacy...
10. House Staffers Mull Strategies To Speed Health Bill Passage CongressDaily: "Congressional Democrats are laying groundwork that would allow the House to pass the Senate's healthcare overhaul bill without a conference, a move that would avoid additional Senate filibusters and...
11. Also In Global Health News: Illegal Drug Trade In E. Africa; Somalia Humanitarian Crisis; Alcohol, IV Drug Use In Russia; HIV/AIDS In China; More Illegal Drug Trade Turning East Africa Into Major Crime Center, U.N. Official Says In a speech to the U.N. Security Council Tuesday, Antonio Maria Costa, head of the U.N. Office...
12. White House Deal With Drug Makers May Be Unraveling "Congressional Democrats' intensifying efforts to pay for their healthcare overhaul and provide more relief for consumers are threatening to unravel a White House deal with the pharmaceutical industry and turn...
13. Cosmetic Surgery Industry Lobbies Against The ‘Botax’ In Senate Health Bill "Leading makers of antiwrinkle drugs, breast implants and other appearance-related products are trying to derail a proposed tax on elective cosmetic surgery in the Senate's health-overhaul bill," The Wall Street...
14. Consumers In Search Of Saving Money Should Reconsider Prescription Drug Choices Americans are increasingly scrutinizing their drug choices to find ones that work but don't break the bank. The Associated Press reports: "Last year pharmaceutical companies spent more than $4 billion...
15. Business Opponents Of Health Overhaul Ramp Up Advertising Interest groups, including business opponents, are ramping up spending on advertising. "Business foes of health care overhaul legislation are outspending supporters at a rate of 2-to-1 for TV ads as...

« Specialty Of Xen-Tan Human Growth Hormone Pills Uses »